Martin R.J. Kolb
McMaster University
1 paper in the Anchorcite directory, published in 2014, cited 4,771 times in total.
ORCID profileResearch topics
- Chronic Obstructive Pulmonary Disease (COPD) Research · 1 paper
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis · 1 paper
- Pulmonary Hypertension Research and Treatments · 1 paper
Frequent co-authors
- Luca Richeldi · 1 paper
- Roland M. du Bois · 1 paper
- Ganesh Raghu · 1 paper
- Arata Azuma · 1 paper
- Kevin M. Brown · 1 paper
- Ulrich Costabel · 1 paper
- Vincent Cottin · 1 paper
- David M. Hansell · 1 paper
Papers
- Efficacy and Safety of Nintedanib in Idiopathic Pulmonary FibrosisNew England Journal of Medicine · 2014 · 4,771 citations
BACKGROUND: Nintedanib (formerly known as BIBF 1120) is an intracellular inhibitor that targets multiple tyrosine kinases. A phase 2 trial suggested that treatment with 150 mg of nintedanib twice daily reduced lung-function decline and acute exacerbations in patients with idiopathic…
Metadata from OpenAlex (CC0).